182 results on '"Pandey, Ambarish"'
Search Results
2. From Hospital to Home: Evidence-Based Care for Worsening Heart Failure
3. Association of disproportionate liver fat with markers of heart failure: The multi-ethnic study of atherosclerosis
4. Interleukin-6 and Cardiovascular Events in Healthy Adults: MESA
5. Peripheral artery disease, chronic kidney disease, and recurrent admissions for acute decompensated heart failure: The ARIC study
6. Association of High-Density Lipoprotein Parameters and Risk of Heart Failure: A Multicohort Analysis
7. Characteristics of High-Performing Hospitals in Cardiogenic Shock Following Acute Myocardial Infarction
8. Patterns, Prognostic Implications, and Rural-Urban Disparities in Optimal GDMT Following HFrEF Diagnosis Among Medicare Beneficiaries
9. Frailty Status Modifies the Efficacy of ICD Therapy for Primary Prevention Among Patients With HF
10. Association of Beta-Blocker Use With Exercise Capacity in Participants With Heart Failure With Preserved Ejection Fraction: A Post Hoc Analysis of the RELAX Trial
11. A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure
12. National Variation in Hospital MTEER Outcomes and Correlation With TAVR Outcomes: STS/ACC TVT Registry Analysis
13. Associations Between Cardiac Function and Brain Health in Diverse Middle-Aged Adults: The Dallas Heart Study-2
14. HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America
15. Role of exercise therapy and cardiac rehabilitation in heart failure
16. Managing Obesity in Heart Failure: A Chance to Tip the Scales?
17. Incident Heart Failure Risk Reclassification With Race-Independent Estimated Glomerular Filtration Rate: A National Heart, Lung, and Blood Institute Pooled Cohorts Analysis
18. Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial
19. Racial differences in low natriuretic peptide levels: Implications for heart failure clinical trials
20. Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America
21. Impact of Geroscience on Therapeutic Strategies for Older Adults With Cardiovascular Disease: JACC Scientific Statement
22. Oxygen Uptake Efficiency Slope and Prognosis in Heart Failure With Reduced Ejection Fraction
23. Association of Non-Alcoholic Fatty Liver Disease With in-Hospital Outcomes in Primary Heart Failure Hospitalizations With Reduced or Preserved Ejection Fraction
24. Neighborhood-level Social Vulnerability and Prevalence of Cardiovascular Risk Factors and Coronary Heart Disease
25. Predicting and preventing heart failure in type 2 diabetes
26. Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society
27. Effect of Canagliflozin on Heart Failure Hospitalization in Diabetes According to Baseline Heart Failure Risk
28. Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on cardiovascular and kidney outcomes in Asian versus White patients with type 2 diabetes mellitus
29. Lifetime healthcare expenses across demographic and cardiovascular risk groups: The application of a novel modeling strategy in a large multiethnic cohort study
30. Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society
31. Inconsistent Outcome Reporting in Heart Failure Randomized Controlled Trials
32. AHA Life's essential 8 and ideal cardiovascular health among young adults
33. Longitudinal Changes in Cardiac Troponin and Risk of Heart Failure Among Black Adults
34. Exercise Training, Cardiac Biomarkers, and Cardiorespiratory Fitness in Type 2 Diabetes: The HART-D Study
35. Physical activity, cardiorespiratory fitness, and cardiovascular health: A clinical practice statement of the American Society for Preventive Cardiology Part I: Bioenergetics, contemporary physical activity recommendations, benefits, risks, extreme exercise regimens, potential maladaptations
36. Physical activity, cardiorespiratory fitness, and cardiovascular health: A clinical practice statement of the American Society for Preventive Cardiology Part II: Physical activity, cardiorespiratory fitness, minimum and goal intensities for exercise training, prescriptive methods, and special patient populations
37. Glycemic Markers and Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA)
38. Trends in Heart Failure–Related Mortality Among Older Adults in the United States From 1999-2019
39. Prevalence and Prognostic Significance of Polyvascular Disease in Patients Hospitalized With Acute Decompensated Heart Failure: The ARIC Study
40. Supranormal Left Ventricular Ejection Fraction, Stroke Volume, and Cardiovascular Risk: Findings From Population-Based Cohort Studies
41. Association Between Thigh Muscle Fat Infiltration and Incident Heart Failure: The Health ABC Study
42. The Relationship Between Atrial Fibrillation, Mitral Regurgitation, and Heart Failure Subtype: The ARIC Study
43. Mid-Life Cardiorespiratory Fitness, Obesity, and Risk of Atrial Fibrillation: The Cooper Center Longitudinal Study
44. Trends in HF Hospitalizations Among Young Adults in the United States From 2004 to 2018
45. Long-Term Cardiovascular Outcomes After Bariatric Surgery in the Medicare Population
46. Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial
47. Association of readmission penalty amount with subsequent 30-day risk standardized readmission and mortality rates among patients hospitalized with heart failure: An analysis of get with the guidelines – heart failure participating centers
48. Clinical Implications of the Amyloidogenic V122I Transthyretin Variant in the General Population
49. Guideline based eligibility for primary prevention statin therapy – Insights from the North India ST-elevation myocardial infarction registry (NORIN-STEMI)
50. Transthyretin V142I Genetic Variant and Cardiac Remodeling, Injury, and Heart Failure Risk in Black Adults
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.